Triaza- and tetraaza-anthracenedione derivatives, their...

Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S251000, C514S250000

Reexamination Certificate

active

07132536

ABSTRACT:
The present invention relates to triaza- and tetraaza-anthracenedione derivatives of the formula I,wherein A, B and R1to R5are as defined herein. The compounds of formula I are valuable pharmacologically active compounds. They are useful in the treatment of various disease states including cardiovascular disorders such as atherosclerosis, thrombosis, coronary artery disease, hypertension and cardiac insufficiency. They upregulate the expression of the enzyme endothelial nitric oxide (NO) synthase and can be applied in conditions in which an increased expression of said enzyme or an increased NO level or the normalization of a decreased NO level is desired. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.

REFERENCES:
patent: 3905976 (1975-09-01), Hardtmann
patent: 4162319 (1979-07-01), Seubert et al.
patent: 5605905 (1997-02-01), Avendano et al.
patent: 6617359 (2003-09-01), Wohlfart et al.
patent: 6759412 (2004-07-01), Strobel et al.
patent: 2002/0143007 (2002-10-01), Garvey et al.
patent: 2003/0022935 (2003-01-01), Strobel et al.
patent: 2003/0055093 (2003-03-01), Strobel et al.
patent: WO 99/47153 (1999-09-01), None
patent: WO 00/03746 (2000-01-01), None
Driver, et al., A Second-Generation Catalyst for Aryl Halide Amination: Mixed Secondary Amines from Aryl Halides and Primary Amines Catalyzed by (DPPF)PdCl2, J. AMer. Chem Soc.; 118; 1996; pp. 7217-7218.
Endres, et al. , Stroke Protection By 3-Hydroxy-3-Methylglutaryl (HMG)—CoA Reductase Inhibitors Medicated By Endothelial Nitric Oxide Synthase, Proc. Natl. Acad. Sci. USA, 95 (1998) 8880-8885.
Ll Huige et al., Activation of Protein Kinase C(alpha) and/or (epsilon) Enhances Transcription of the Human Endothelial Nitric Oxide Synthase Gene, Mol. Pharmacol., 1998,vol. 53, pp. 630-637.
Martin-Santamaria, et al., Synthesis and Stereochemistry of 11,11a-Dihydro Derivatives of (4S)-2,4-Dimethyl-2,4dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-diones. A New Transannular Rearrangement Proposal., J. Org.Chem.; 64; 1999; pp. 7233-7235.
Moroi, et al. , Interaction of Genetic Deficiency of Endothelial Nitric Oxide, Gender, and Pregnancy in Vascular Response to Injury in Mice, J. Clin. Invest., 101 (1998) 1225-1232.
Nakayama Masafumi et al., T-786→C Mutation in the 5′-Flanking Region of the Endothelial Ntric Oxide Synthase Gene Is Associated with Coronary Spasm, Clinical Investigation and Reports, Circulation 99, 1999, pp. 2864-2870.
Sessa, et al., Chronic Exercise In Dogs Increases Coronary Vascular Nitric Oxide Production And Endothelial Cell Nitric Oxide Synthase Gene Expression, Circ. Research 74 (1994) 349-353.
Varenne, et al. , Percutaneous Gene Therapy Using Recombinant Adenoviruses Encoding Human Herpes Simplex Virus Thymidine Kinase, Human PAI-1, and Human NOS3 In Balloon-Injured Porcine Coronary Arteries, Hum. Gene Ther. 11 (2000) 1329-1339.
Vojkovsky, et al., Solid-Phase Synthesis of Heterocycles Containing an 1-Acyl-3-oxopiperazine Skeleton, J. Org. Chem.; 63; 1998; pp. 3162-3163.
U.S. Appl. No. 10/146,671, filed May 16, 2002, Garvey et al.
U.S. Appl. No. 10/073,160, filed Feb. 13, 2002, Strobel.
U.S. Appl. No. 10/073,203, filed Feb. 13, 2002, Strobel.
U.S. Appl. No. 10/073,307, filed Feb. 13, 2002, Strobel.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Triaza- and tetraaza-anthracenedione derivatives, their... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triaza- and tetraaza-anthracenedione derivatives, their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triaza- and tetraaza-anthracenedione derivatives, their... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3650815

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.